Clinical and biological significance of<i>de novo</i>CD5+ diffuse large B-cell lymphoma in Western countries
Zijun Y. Xu‐Monette(Duke University), Ken H. Young(Duke Medical Center), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Maurilio Ponzoni(San Raffaele University of Rome), Yuji An(The University of Texas MD Anderson Cancer Center), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Qingqing Cai(Sun Yat-sen University), Xin Cao(Beijing Tsinghua Chang Gung Hospital), Kristy L. Richards(University of North Carolina at Chapel Hill), April Chiu(Mayo Clinic), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Youli Zu(Methodist Hospital), John P. Farnen(Gundersen Health System), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Xiaoying Zhao(Handan College), Jooryung Huh(Hallym University), William W.L. Choi(Chinese University of Hong Kong), Meifeng Tu(Peking University), L. Jeffrey Medeiros(Delaware Division of Libraries), Kausar J. Jabbar(Beaumont Health), Jane N. Winter(Northwestern University)
Cited by 93
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k